Segment Reporting - Summary of Significant Segment Expenses (Details) - USD ($) $ in Thousands |
3 Months Ended | 6 Months Ended | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
Jun. 30, 2025 |
Mar. 31, 2025 |
Jun. 30, 2024 |
Mar. 31, 2024 |
Jun. 30, 2025 |
Jun. 30, 2024 |
|||||
| Segment Reporting Information [Line Items] | ||||||||||
| Research and development expenses | $ (22,882) | $ (16,879) | $ (46,225) | $ (33,932) | ||||||
| General and Administrative | [1] | (5,731) | (5,883) | (11,423) | (11,145) | |||||
| Other Segment Items | [2] | 1,594 | 2,425 | 3,146 | 5,034 | |||||
| Net loss | (27,019) | $ (27,483) | (20,337) | $ (19,706) | (54,502) | (40,043) | ||||
| Clinical, Preclinical, and R&D Operations | ||||||||||
| Segment Reporting Information [Line Items] | ||||||||||
| Research and development expenses | [1] | (16,811) | (12,123) | (33,197) | (23,623) | |||||
| Chemistry, Manufacturing and Controls | ||||||||||
| Segment Reporting Information [Line Items] | ||||||||||
| Research and development expenses | [1] | $ (6,071) | $ (4,756) | $ (13,028) | $ (10,309) | |||||
| ||||||||||
| X | ||||||||||
- Definition Other segment items. No definition available.
|
| X | ||||||||||
- Definition The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount of expense for research and development. Includes, but is not limited to, cost for computer software product to be sold, leased, or otherwise marketed and writeoff of research and development assets acquired in transaction other than business combination or joint venture formation or both. Excludes write-down of intangible asset acquired in business combination or from joint venture formation or both, used in research and development activity. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. No definition available.
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|